Literature DB >> 26438059

Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.

Jiahui Dong1, Gengyun Sun2, Hongbin Zhu3.   

Abstract

Diagnosis of malignant pleural effusion (MPE) remains a major clinical challenge. The aim of this study was to evaluate the diagnostic value of combined detection of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) and carcinoembryonic antigen (CEA) in patients with MPE and benign pleural effusion (BPE). The serum and pleural fluid samples were collected from 53 patients diagnosed with MPE and 49 patients with BPE. Enzyme-linked immunosorbent assay was used to detect the concentration of RCAS1 in serum and pleural effusion. The clinical data and laboratory information, including CEA levels, were gathered from these cases. The concentration of RCAS1 in MPE was significantly higher than that of BPE (P < 0.001). There was no significant difference between the two serum groups. The diagnostic sensitivity and specificity of pleural fluid RCAS1 were 67.92 and 81.63 %, respectively, at the optimized cutoff value of 7.326 U/mL; meanwhile, the sensitivity and specificity of pleural fluid CEA were 83.02 and 91.84 % at the cutoff value of 3.93 ng/mL. The specificity could be elevated to 98.50 % in serial detection, while the sensitivity may be improved to 94.55 % in parallel detection. Serum RCAS1 concentration was only detected in 53 serum samples out of the 102 samples, indicating that serum RCAS1 may not be a better option in differential diagnosis of malignancies compared with serum CEA, of which the diagnostic sensitivity and specificity were 64.15 and 83.67 % at the cutoff value of 3.90 ng/mL. No significant differences were found in pleural fluid RCAS1 concentration in MPE patients with different ages, gender, and pathological types of lung cancers. The detection of RCAS1 concentration in pleural fluid is informative for the diagnosis of MPE. Joint detection of RCAS1 and CEA can improve the diagnostic sensitivity and specificity. However, the diagnostic value of RCAS1 is not higher than that of CEA.

Entities:  

Keywords:  Carcinoembryonic antigen; Diagnosis; Pleural effusion, malignant; Receptor-binding cancer antigen expressed on SiSo cells

Mesh:

Substances:

Year:  2015        PMID: 26438059     DOI: 10.1007/s13277-015-4174-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010.

Authors:  Clare Hooper; Y C Gary Lee; Nick Maskell
Journal:  Thorax       Date:  2010-08       Impact factor: 9.139

2.  Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.

Authors:  P Riantawan; P Sangsayan; K Bangpattanasiri; P Rojanaraweewong
Journal:  Respiration       Date:  2000       Impact factor: 3.580

3.  Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.

Authors:  Akio Hiraki; Keisuke Aoe; Tomoyuki Murakami; Yuichi Nakamura; Koich Yamazaki; Naoko Sueoka; Koji Taguchi; Toshiaki Kamei; Tadashi Maeda; Hiroyasu Takeyama; Takumi Kishimoto; Masaharu Nishimura; Kazuro Sugi
Journal:  Oncol Rep       Date:  2005-08       Impact factor: 3.906

4.  Analysis of cell cycle arrest and apoptosis induced by RCAS1.

Authors:  Takuya Nishinakagawa; Sho Fujii; Tetsuya Nozaki; Tatsuhiro Maeda; Kazuyuki Machida; Munechika Enjoji; Manabu Nakashima
Journal:  Int J Mol Med       Date:  2010-05       Impact factor: 4.101

5.  Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion.

Authors:  Mohamed Y Elsammak; Adel Attia; Hoda A Hassan; Taysser M Zaytoun; Mahmoud Shorman; Moosa Suleman
Journal:  Tumour Biol       Date:  2012-06-09

Review 6.  Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis.

Authors:  Q-L Liang; H-Z Shi; X-J Qin; X-D Liang; J Jiang; H-B Yang
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

Review 7.  The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis.

Authors:  Kenzo Sonoda; Shingo Miyamoto; Manabu Nakashima; Norio Wake
Journal:  Front Biosci       Date:  2008-01-01

8.  Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis.

Authors:  Huan-Zhong Shi; Qiu-Li Liang; Jing Jiang; Xue-Jun Qin; Hai-Bo Yang
Journal:  Respirology       Date:  2008-04-14       Impact factor: 6.424

9.  Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.

Authors:  Thomas Muley; Timea-Helene Fetz; Hendrik Dienemann; Hans Hoffmann; Felix J F Herth; Michael Meister; Werner Ebert
Journal:  Lung Cancer       Date:  2008-02-20       Impact factor: 5.705

10.  Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.

Authors:  Amelia O Clive; Brennan C Kahan; Clare E Hooper; Rahul Bhatnagar; Anna J Morley; Natalie Zahan-Evans; Oliver J Bintcliffe; Rogier C Boshuizen; Edward T H Fysh; Claire L Tobin; Andrew R L Medford; John E Harvey; Michel M van den Heuvel; Y C Gary Lee; Nick A Maskell
Journal:  Thorax       Date:  2014-08-06       Impact factor: 9.139

View more
  2 in total

1.  Single-step and ultrasensitive detection of carcinoembryonic antigen based on an aptamer transduction-mediated exonuclease III-assisted dual-amplification strategy.

Authors:  Ruojun Lu; Shengqiang Li; Meihong Fan; Jingjing Wei; Xu Liu
Journal:  RSC Adv       Date:  2018-04-18       Impact factor: 4.036

2.  Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.

Authors:  Tiantian Zhang; Wei Liu; Li Li; Zou Jue; Chunhua Xu
Journal:  BMC Pulm Med       Date:  2022-08-10       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.